IL150034A0 - Oral mucosal dosage forms of apomorphine - Google Patents

Oral mucosal dosage forms of apomorphine

Info

Publication number
IL150034A0
IL150034A0 IL15003400A IL15003400A IL150034A0 IL 150034 A0 IL150034 A0 IL 150034A0 IL 15003400 A IL15003400 A IL 15003400A IL 15003400 A IL15003400 A IL 15003400A IL 150034 A0 IL150034 A0 IL 150034A0
Authority
IL
Israel
Prior art keywords
apomorphine
dosage forms
oral mucosal
mucosal dosage
oral
Prior art date
Application number
IL15003400A
Other languages
English (en)
Original Assignee
Tap Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tap Holdings Inc filed Critical Tap Holdings Inc
Publication of IL150034A0 publication Critical patent/IL150034A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
IL15003400A 1999-12-30 2000-12-19 Oral mucosal dosage forms of apomorphine IL150034A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47584499A 1999-12-30 1999-12-30
PCT/US2000/034548 WO2001049292A1 (en) 1999-12-30 2000-12-19 Oral mucosal dosage forms of apomorphine

Publications (1)

Publication Number Publication Date
IL150034A0 true IL150034A0 (en) 2002-12-01

Family

ID=23889387

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15003400A IL150034A0 (en) 1999-12-30 2000-12-19 Oral mucosal dosage forms of apomorphine

Country Status (14)

Country Link
EP (1) EP1242088A1 (hu)
JP (1) JP2004501065A (hu)
CN (1) CN1414853A (hu)
AU (1) AU2440901A (hu)
BR (1) BR0012822A (hu)
CA (1) CA2394297A1 (hu)
CZ (1) CZ20022245A3 (hu)
HK (1) HK1051315A1 (hu)
HU (1) HUP0400495A3 (hu)
IL (1) IL150034A0 (hu)
MX (1) MXPA02006034A (hu)
NO (1) NO20023190L (hu)
PL (1) PL366204A1 (hu)
WO (1) WO2001049292A1 (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0202365D0 (sv) 2002-08-05 2002-08-05 Pharmacia Ab New formulation and use thereof
WO2004064811A1 (en) * 2003-01-24 2004-08-05 Magle Holding Ab A composition material for transmucosal delivery
SE0302947D0 (sv) 2003-01-24 2003-11-07 Magle Ab A composition material for transmucosal delivery
EP1738754B1 (en) * 2004-04-14 2015-07-15 Takeda Pharmaceutical Company Limited Solid pharmaceutical preparation
GB0509317D0 (en) * 2005-05-06 2005-06-15 Clarke Anthony Pharmaceutical formulation of apomorphine
DK2442650T3 (en) * 2009-06-12 2015-12-07 Cynapsus Therapeutics Inc sublingual apomorphine
US20220249465A1 (en) * 2019-05-31 2022-08-11 Primo Pharmatech Llc Unit dosage form for transmucosal drug delivery of an active pharmaceutical ingredient

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994022445A2 (en) * 1993-03-26 1994-10-13 Merkus Franciscus W H M Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine
GB9517062D0 (en) * 1995-08-18 1995-10-25 Scherer Ltd R P Pharmaceutical compositions

Also Published As

Publication number Publication date
NO20023190D0 (no) 2002-07-01
HUP0400495A3 (en) 2007-05-02
WO2001049292A1 (en) 2001-07-12
NO20023190L (no) 2002-08-29
HK1051315A1 (zh) 2003-08-01
EP1242088A1 (en) 2002-09-25
JP2004501065A (ja) 2004-01-15
MXPA02006034A (es) 2004-08-23
HUP0400495A2 (hu) 2004-06-28
CZ20022245A3 (cs) 2002-10-16
CA2394297A1 (en) 2001-07-12
PL366204A1 (en) 2005-01-24
CN1414853A (zh) 2003-04-30
AU2440901A (en) 2001-07-16
BR0012822A (pt) 2004-03-09

Similar Documents

Publication Publication Date Title
HUP0203204A3 (en) Oral dosage forms
EG23943A (en) Flash-melt oral dosage formulation
HK1090840A1 (en) Extended release oral dosage composition
EG23759A (en) Stable extended release oral dosage composition
ZA200202480B (en) Oral dosage forms.
AU1998200A (en) Multiparticulate oral dosage forms
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
AU2003238670A8 (en) Fast disintegrating oral dosage forms
IL166337A0 (en) Oral administration of calctionin
HUP0500638A3 (en) Flashmelt oral dosage formulation
PL340456A1 (en) Novel oral dosage form of carvedilol
IL150034A0 (en) Oral mucosal dosage forms of apomorphine
HUP0201667A3 (en) Oral form of administration
GB9923045D0 (en) New oral formulations
PL352062A1 (en) Oral solution of prucalopride
HUP0401599A3 (en) Extended release oral dosage form
EP1210935A4 (en) DRUGS FOR ORAL USE
HK1047232A1 (zh) 口服劑型
GB9925069D0 (en) Oral dosage form
IL132006A0 (en) Stable pharmaceuticl oral dosage forms
GB0014497D0 (en) Oral dosage form
GB9911839D0 (en) Invention related to oral hygiene
GB0030587D0 (en) Oral administration of beneficial substances
PL341178A1 (en) Oral pharmaceutical dosage forms
GB9930266D0 (en) Oral administration of beneficial substances